Session Details

U092 Advances in Microneedling Techniques Around the World

Mon, Mar 30, 7:30 AM - 8:30 AM
Mile High 2C
1 CME Available Focus Session Upcoming
View Map

DESCRIPTION

The session aims to present updated, evidence-based practices and clinical pearls with a global perspective, using microneedling and other needling procedures in a safe and effective way to manage various common dermatoses. Conditions to be reviewed may include scars of various etiologies, striae distensae, pigmentary dermatoses and rhytides. The use of microneedling to facilitate transdermal drug delivery will additionally be reviewed. Microneedling and radiofrequency microneedling will be compared and discussed. Topics to be presented will include assessment approaches, supporting recent literature, clinical pearls and experiences, and discussion of adverse effects and management options.

LEARNING OBJECTIVES

1.

Demonstrate the safe and effective use of microneedling in patients with various common dermatoses as performed in real-world clinical practice

2.

Evaluate evidence-based practices using microneedling (vs. radiofrequency microneedling) for scars, striae and rhytides based on clinical experience and research

3.

Formulate approaches and treatment plans that integrate microneedling, to optimize outcomes and minimize adverse effects, when targeting aesthetic and medical skin needs of patients, across the skin spectrum

SCHEDULE

7:30 AM

Introductions and Welcome

Monica Ka Yi Li, MD, FAAD, Tina S. Alster, MD, FAAD

7:32 AM

Microneedling with polynucleotides and exosomes for skin and hair: Experiences from India

Chytra V. Anand, MBBS, MSc, IFAAD

7:45 AM

Microneedling for expanded indications: Clinical Applications and Advances in Korea

Boncheol Goo

7:58 AM

Facial contour changes and fat loss concerns after RF Microneedling: Preliminary 3D observations from Taiwan

Po-Han Huang, MD, IFAAD

8:11 AM

Panel discussion and Q&A

DIRECTOR

Monica Ka Yi Li, MD, FAAD

Monica Ka Yi Li, MD, FAAD

CO-DIRECTOR

Tina S. Alster, MD, FAAD

Tina S. Alster, MD, FAAD

SPEAKERS

Chytra V. Anand, MBBS, MSc, IFAAD

Chytra V. Anand, MBBS, MSc, IFAAD

Boncheol Goo

Boncheol Goo

Po-Han Huang, MD, IFAAD

Po-Han Huang, MD, IFAAD

DISCLOSURES

Tina S. Alster, MD, FAAD

A Method – Consultant(Other Financial Benefit); Hair Sanity – Stockholder(Stock); PhyNet Dermatology – Employee (w-2 relationship)(Salary);

Chytra V. Anand, MBBS, MSc, IFAAD

Allergan Aesthetics – Consultant (1099 relationship)(Fees); Alma Lasers – Speaker/Faculty Education(Fees); Merz Aesthetics – Other(No Compensation Received);

Boncheol Goo

Agnes Medical – Board of Directors(Patent royalties or other compensation for Intellectual Property Rights); Classys – Advisory Board(Honoraria); Colgate-Palmolive – Advisory Board(Honoraria); Pharmaresearch – Advisory Board(Honoraria); Speclipse – Board of Directors(Stock Options);

Po-Han Huang, MD, IFAAD

ExoCoBio – Speaker(Honoraria); Fastox Pharma – Stockholder Private Company(Stock); Quanta System S.p.A – Speaker(Honoraria);

Monica Ka Yi Li, MD, FAAD

Amore Pacific – Speaker(Honoraria); Bausch Health – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Beiersdorf, Inc. – Consultant(Honoraria), Speaker(Honoraria); Candela Corporation – Consultant(Honoraria), Other(Equipment), Speaker(Honoraria); Cipher Pharmaceuticals – Speaker(Honoraria); Endo Pharmaceuticals – Advisory Board(Honoraria); Galderma Canada, Inc – Speaker(Non-accredited CME Education Grant); Galderma Global – Advisory Board(Honoraria); Kenvue – Advisory Board(Honoraria), Other(No Compensation Received); L'Oreal USA Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Merz Aesthetics – Speaker(Honoraria); Pfizer Inc. – Consultant(Honoraria), Speaker(Honoraria); Pierre Fabre – Speaker(Honoraria); Procter & Gamble Company – Consultant(Honoraria); Searchlight Pharma – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria);